Skip to main content Skip to main menu
UF Health University of Florida
Office of Clinical Research (OCR) Clinical and Translational Science Institute
COVID-19 Response
Services Overview

Confidential Disclosure Agreements

What is a Confidential Disclosure Agreement (CDA)?

A Confidential Disclosure Agreement (CDA), also know as a non-disclosure agreement (NDA), is a legal contract between at least two parties that outlines confidential material, knowledge, or information that the parties wish to share with one another for certain purposes, but wish to restrict access to, or by, third parties.

When is a CDA/NDA Used?

CDAs are used when the parties are considering a relationship or collaboration together and need to understand the other’s processes, methods, or technology solely for the purpose of evaluating the potential for a future relationship.

Who Negotiates Clinical Research CDA/NDAs for UF?

The UF Office of Clinical Research (OCR) contracting team negotiates all clinical research CDAs for UF.

How are Clinical Research CDA/NDAs Processed?

  • Sponsor sends a Confidential Disclosure or Non-disclosure Agreement (CDA/NDA) draft (in an editable format) to be negotiated and executed by OCR for UF.
  • Note: Typically, the Sponsor will send CDA/NDA directly to the Principal Investigator(PI); PI should NOT sign!
  • Study team places the draft CDA/NDA into the UFIRST Agreement Module.
  • The OCR Contracting team will negotiate and prepare the CDA/NDA for execution by UF Authorized Signing Official.
  • OCR will send partially executed CDA/NDA back to sponsor for final signature.
  • Sponsor sends a copy of the fully executed CDA/NDA to OCR.
  • OCR files the fully executed CDA/NDA into the UFIRST Agreement Module.

Resources

Questions?